No abstract available
Keywords:
Alirocumab; Evolocumab; Lipid-lowering; PCSK9 inhibitor; Statin; Stroke.
MeSH terms
-
Anticholesteremic Agents*
-
Cardiovascular Diseases*
-
Humans
-
Proprotein Convertase 9
-
Stroke* / prevention & control
-
Subtilisins
Substances
-
Anticholesteremic Agents
-
Proprotein Convertase 9
-
Subtilisins